(Q24243298)

8

0 references

Frank Rauch

object named as

Frank Rauch

7

0 references

Andrea C. Tricco

2

object named as

Andrea Tricco

0 references

author name string

Leanne Ward

1

0 references

Phuc-Nhi Phuong

3

0 references

Ann Cranney

4

0 references

Nick Barrowman

5

0 references

Isabelle Gaboury

Cochrane Database of Systematic Reviews

6

0 references

publication date

17 October 2007

0 references

published in

0 references

cites work

Pamidronate treatment of pediatric fracture patients on chronic steroid therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Treatment of osteopenia and osteoporosis in renal transplant children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Case reports and case series from Lancet had significant impact on medical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Use of bisphosphonate therapy for osteoporosis in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

New approaches for interpreting projected bone densitometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Association between bone density and fractures in children: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Osteoporosis at presentation of childhood ALL: management with pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Short-term safety assessment in the use of intravenous zoledronic acid in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Pamidronate treatment improves bone mineral density in children with Menkes disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation, and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

The use of pamidronate in three children with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Osteopenia in cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Intravenous pamidronate in juvenile osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Bony morbidity in children treated for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Vertebral Fractures and Increased Sensitivity to Corticosteroids in a Child With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Influence of steroid medication on bone mineral density in children with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Analysis of muscle strength and bone structure in children with renal disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Expanding role of bisphosphonate therapy in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Epidemiology and reporting of randomised trials published in PubMed journals

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Severe skeletal complications in a child with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Osteoporosis in children with severe congenital neutropenia: bone mineral density and treatment with bisphosphonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005324.PUB2

7 January 2021

10.1002/14651858.CD005324.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17943849

1 reference

Consolidated OpenCitations Corpus – April 2017